Introduction

In a closely watched artificial sweetener patent dispute, the U.S. Court of Appeals for the Federal Circuit affirmed the International Trade Commission’s ruling against Celanese Corp. in Case No. 22-1827, ultimately dismissing the appeal on August 12, 2024. The case centered on five patents covering acesulfame potassium (Ace-K) synthesis technology — a high-stakes artificial sweetener used globally in food, beverage, and pharmaceutical products.

Filed on May 26, 2022, and resolved after 809 days, this acesulfame potassium patent litigation highlights the procedural and substantive challenges patent holders face when appealing ITC determinations to the Federal Circuit. For patent attorneys, IP professionals, and R&D teams operating in the specialty chemicals and food ingredient sectors, the case offers critical lessons about ITC appeals strategy, patent portfolio management, and freedom-to-operate risk assessment.

With Morrison & Foerster representing Celanese and ITC counsel anchoring the defense, this dispute underscores the complexity of enforcing synthesis-related chemical patents before U.S. trade authorities.

Case Overview

The Parties

The Patents at Issue

Five U.S. patents were asserted, all directed to acesulfame potassium (Ace-K) manufacturing technology, covering chemical synthesis processes and compositions related to Ace-K production.

• • US10590095 (App. No. 16/273,358) — Ace-K synthesis technology
• • US10023546 (App. No. 15/704,457) — Ace-K synthesis technology
• • US10208004 (App. No. 16/014,552) — Ace-K synthesis technology
• • US10233163 (App. No. 16/014,431) — Ace-K synthesis technology
• • US10590098 (App. No. 16/273,454) — Ace-K synthesis technology

Litigation Timeline & Procedural History

The case originated as an ITC Section 337 investigation — the standard trade remedy mechanism for excluding infringing imported products — before Celanese escalated its challenge to the Federal Circuit. Filed in the District of Columbia jurisdiction consistent with ITC appeal procedure, the case ran for approximately 27 months before resolution.

The 809-day duration reflects the typical complexity of Federal Circuit ITC appeals, which require full briefing on administrative records that often span thousands of pages. No chief judge data was disclosed in the case record. The basis of termination — Appeal Dismissed / Affirmed — indicates the Federal Circuit upheld the ITC’s underlying determination and declined to reverse or remand on Celanese’s asserted grounds.

The Verdict & Legal Analysis

Outcome

The Federal Circuit affirmed the ITC’s determination and dismissed Celanese’s appeal in Case No. 22-1827. No specific damages award is applicable in this context, as ITC Section 337 proceedings do not award monetary damages — relief typically takes the form of exclusion orders or cease-and-desist orders against infringing importation. The affirmance signals that the ITC’s original findings on the merits withstood Federal Circuit scrutiny.

Verdict Cause Analysis

The case was designated as an infringement action, meaning the core dispute involved whether the accused acesulfame potassium products or processes infringed one or more of Celanese’s five asserted patents. In ITC proceedings subsequently appealed to the Federal Circuit, common grounds for reversal include:

• Claim construction errors — misinterpretation of patent claim scope at the ITC level
• Substantial evidence challenges — arguing the administrative record did not support the ITC’s factual findings
• Validity defenses — obviousness or anticipation arguments that could invalidate asserted claims

The Federal Circuit’s decision to affirm — rather than reverse or remand — indicates Celanese did not successfully demonstrate that the ITC’s legal interpretations or factual findings were erroneous under the applicable standard of review. Specific claim construction rulings and evidentiary findings from the underlying ITC investigation were not disclosed in the provided case data; practitioners seeking full legal reasoning should consult the Federal Circuit’s published opinion via USPTO Patent Center or PACER.

Legal Significance

This case carries meaningful precedential weight for chemical synthesis patent enforcement at the ITC. The Federal Circuit’s affirmance reinforces the evidentiary deference afforded to ITC Administrative Law Judge findings when appealed. For patent holders asserting process patents in the specialty chemicals space, the case illustrates that:

1. ITC exclusion proceedings are not easily reversed on appeal absent clear legal error.
2. Multi-patent assertion strategies — here involving five related patents — do not automatically increase appellate leverage if the underlying infringement findings are unfavorable.
3. Claim scope definition during prosecution remains critical, as post-grant claim construction disputes are notoriously difficult to overcome on appeal.

Strategic Takeaways

For Patent Holders: Celanese’s unsuccessful appeal underscores the importance of frontloading patent claim drafting strategy. Broad, clearly written process claims in chemical synthesis patents must survive both ITC claim construction and Federal Circuit de novo legal review. Patent holders should evaluate ITC appeal viability rigorously before committing to lengthy Federal Circuit proceedings.

For Accused Infringers: The affirmance validates that robust ITC defense — built on thorough prior art development and claim construction arguments — can withstand appellate challenge. Design-around efforts for Ace-K synthesis processes should be documented contemporaneously to support FTO positions.

For R&D Teams: Companies developing or sourcing artificial sweeteners, particularly Ace-K, should conduct freedom-to-operate analyses against the five Celanese patents identified in this case. Even with the appeal dismissed, the underlying patents (US10590095, US10023546, US10208004, US10233163, US10590098) remain active and enforceable.

Industry & Competitive Implications

The Ace-K market is dominated by a small number of global producers, with Chinese manufacturers holding significant production capacity. ITC Section 337 actions targeting Ace-K imports represent a strategic tool for U.S.-based patent holders to protect market position against lower-cost foreign competition. Celanese’s decision to pursue both ITC proceedings and a Federal Circuit appeal signals the commercial magnitude of Ace-K patent rights.

The Federal Circuit’s affirmance may embolden competing Ace-K producers who successfully defended ITC claims, while simultaneously signaling to Celanese — and similarly situated chemical companies — that ITC exclusion orders require airtight patent positions and infringement theories before they can be successfully obtained and sustained.

Broader implications for the specialty chemicals and food ingredient patent litigation landscape include increasing use of ITC proceedings as a complement to district court infringement suits, growing scrutiny of process patent claims in synthesis-heavy industries, and the rising cost of multi-patent ITC campaigns when appellate outcomes are uncertain.

Companies licensing Ace-K technology or developing next-generation sweetener synthesis processes should monitor related Federal Circuit and PTAB activity involving these five Celanese patents.